BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 17.15
+0.23 (1.39%)
Oct 9, 2026, 3:59 PM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 193.95 million as of October 9, 2026. It is the 23,375th most valuable company in the world and the 614th biggest in Canada. Its market cap has increased by 46.57% in one year.
Market Cap
193.95M
Enterprise Value
188.14M
Revenue
55.67M
Global Rank
Country Rank
#614 Canada
PE Ratio
20.08
ChartMarket Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 193.95M, an increase of 1,368.66%. That is a compound annual growth rate of 9.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 193.95M | 35.28% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 346.92M |
| Auxly Cannabis Group | 344.81M |
| Cresco Labs | 341.28M |
| TerrAscend | 224.15M |
| Cardiol Therapeutics | 207.94M |
| Cannara Biotech | 205.33M |
| Organigram Global | 193.18M |
| Medexus Pharmaceuticals | 155.56M |